Literature DB >> 16001094

Atypical antipsychotics: sleep, sedation, and efficacy.

Del D Miller1.   

Abstract

Patients with schizophrenia often suffer from sleep disturbances such as excessive sleeping and insomnia. Common medications for schizophrenia can have a sedative effect on patients. Not all antipsychotic medications have the same sedative effect, which is related to dosage and affinity for histamine H1 receptors. Studies have shown that, compared with conventional antipsychotics, atypical antipsychotics such as risperidone, olanzapine, quetiapine, and ziprasidone generally cause less sedation yet are as effective in controlling psychosis and agitation. Sedation can be troublesome to patients who are trying to become re-integrated into society and interfere with their treatment regimen. Both persistent sedation and chronic insomnia can be managed by the physician.

Entities:  

Year:  2004        PMID: 16001094      PMCID: PMC487011     

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  14 in total

1.  Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.

Authors:  E Richelson; T Souder
Journal:  Life Sci       Date:  2000-11-24       Impact factor: 5.037

2.  Is psychosis exacerbated by modafinil?

Authors:  Rajesh Narendran; Carolyn M Young; Antoinette M Valenti; Maria K Nickolova; Cynthia A Pristach
Journal:  Arch Gen Psychiatry       Date:  2002-03

3.  Three case reports of modafinil use in treating sedation induced by antipsychotic medications.

Authors:  Eugene H Makela; Karla Miller; William D Cutlip
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

4.  5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.

Authors:  C Idzikowski; F J Mills; R Glennard
Journal:  Brain Res       Date:  1986-07-16       Impact factor: 3.252

5.  Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.

Authors:  G W Currier; G M Simpson
Journal:  J Clin Psychiatry       Date:  2001-03       Impact factor: 4.384

6.  Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol.

Authors:  Hidehisa Yamashita; Shigeru Morinobu; Shigeto Yamawaki; Jun Horiguchi; Masatsugu Nagao
Journal:  Psychiatry Res       Date:  2002-03-15       Impact factor: 3.222

7.  Rapid eye movement sleep eye movements in schizophrenia and depression.

Authors:  K L Benson; V P Zarcone
Journal:  Arch Gen Psychiatry       Date:  1993-06

8.  Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment.

Authors:  R Tandon; J E Shipley; S Taylor; J F Greden; A Eiser; J DeQuardo; J Goodson
Journal:  Arch Gen Psychiatry       Date:  1992-03

9.  Calming versus sedative effects of intramuscular olanzapine in agitated patients.

Authors:  John Battaglia; Stacy R Lindborg; Karla Alaka; Karena Meehan; Padraig Wright
Journal:  Am J Emerg Med       Date:  2003-05       Impact factor: 2.469

10.  Risperidone in the treatment of schizophrenia.

Authors:  S R Marder; R C Meibach
Journal:  Am J Psychiatry       Date:  1994-06       Impact factor: 18.112

View more
  36 in total

1.  Fewer classes of drugs for more and more psychiatric disorders.

Authors:  L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2006-03       Impact factor: 6.186

2.  Safety and tolerability of antipsychotic polypharmacy.

Authors:  Juan A Gallego; Jimmi Nielsen; Marc De Hert; John M Kane; Christoph U Correll
Journal:  Expert Opin Drug Saf       Date:  2012-05-08       Impact factor: 4.250

3.  Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice.

Authors:  Olajide S Annafi; Oritoke M Aluko; Anthony T Eduviere; Osarume Omorogbe; Solomon Umukoro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-13       Impact factor: 3.000

4.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

5.  Is seroquel developing an illicit reputation for misuse/abuse?

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2010-01

Review 6.  Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Lei Xia; Wen-Zheng Li; Huan-Zhong Liu; Rui Hao; Xiang-Yang Zhang
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-01-22       Impact factor: 2.576

Review 7.  Sleep and Transportation Safety: Role of the Employer.

Authors:  David Rainey; Michael A Parenteau; Stefanos N Kales
Journal:  Sleep Med Clin       Date:  2019-09-25

8.  Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.

Authors:  Sandhya Mehta; Hua Chen; Michael L Johnson; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 3.923

9.  Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.

Authors:  Zainab Al-Dhaher; Sandeep Kapoor; Ema Saito; Scott Krakower; Lisa David; Theodore Ake; John M Kane; Christoph U Correll; Maren Carbon
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-04-19       Impact factor: 2.576

10.  Asenapine effects in animal models of psychosis and cognitive function.

Authors:  Hugh M Marston; Jared W Young; Frederic D C Martin; Kevin A Serpa; Christopher L Moore; Erik H F Wong; Lisa Gold; Leonard T Meltzer; Marc R Azar; Mark A Geyer; Mohammed Shahid
Journal:  Psychopharmacology (Berl)       Date:  2009-05-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.